Response to Concerns Regarding Intensive Chemoprophylaxis During Influenza Outbreaks in Nursing Homes
-
By
-
Andrew R. Zullo
-
Joe B. B. Silva
-
Stefan Gravenstein
-
September 1, 2026
Clinical Scorecard: Response to Concerns Regarding Intensive Chemoprophylaxis During Influenza Outbreaks in Nursing Homes
At a Glance
| Category | Detail |
|---|
| Condition | Influenza outbreaks in nursing homes |
| Key Mechanisms | Oseltamivir chemoprophylaxis administered via electronic medication administration records (eMAR) |
| Target Population | Nursing home residents |
| Care Setting | Nursing homes |
Key Highlights
- Oseltamivir administration tracked through eMAR data
- Study acknowledges potential bias due to NH characteristics
- Censoring after a 2-day grace period affects risk assessment
- Encouragement for replication studies using eMAR data
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Residents of nursing homes during influenza outbreaks
eMAR data provides accurate tracking of medication administration
Clinical Best Practices
Related Resources & Content
